It is worth noting that a large number of clinical data have shown that patients with high-risk neuroblastoma are often accompanied by abnormal amplification and high-level expression of the MYCN gene [5,6], suggesting that the MYCN gene plays an important role in tumor malignancy and development. The gene discussed is MYCN; the disease is neuroblastoma.